Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 7/20 | 0.72 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 6/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23735538 | 0.98 | EPHX1 (0.68) | EPHX1PRMT1KDM4EMAPK1HIF1A | |
| SCHEMBL23735536 | 0.93 | EPHX1 (0.61) | EPHX1PRMT1EPHX2ACHE | |
| SCHEMBL7788937 | 0.93 | EPHX1 (0.82) | EPHX1KDM4EMAPK1HIF1ATDP1 | |
| SCHEMBL7788569 | 0.93 | EPHX1 (0.82) | EPHX1KDM4EMAPK1HIF1ATDP1 | |
| SCHEMBL14252129 | 0.93 | EPHX1 (0.82) | EPHX1KDM4EMAPK1HIF1ATDP1 | |
| SCHEMBL717081 | 0.93 | EPHX1 (0.82) | EPHX1KDM4EMAPK1HIF1ATDP1 | |
| SCHEMBL7788927 | 0.93 | EPHX1 (0.82) | EPHX1KDM4EMAPK1HIF1ATDP1 | |
| SCHEMBL7252127 | 0.90 | EPHX1 (0.77) | EPHX1KDM4EMAPK1HIF1ATDP1 | |
| SCHEMBL23735539 | 0.89 | EPHX1 (0.59) | EPHX1PRMT1KDM4EMAPK1HIF1A | |
| SCHEMBL23735424 | 0.86 | EPHX1 (0.55) | EPHX1PRMT1TDP1EPHX2ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3157978-B1 | STRICTLY SEGMENTED THERMOPLASTIC ELASTOMERS AS BIODEGRADABLE BIOMATERIALS | SYMO CHEM B V (NL) | 2021-08-11 | — | — | EP | disclosed |